Table 2 Results of the linear mixed model, predicting median RTs to investigate tACS treatment effects.
Predictor | N | Beta | 95% CI | Std. Beta | Std. 95% CI | p value |
---|---|---|---|---|---|---|
Group | 0.4 | |||||
Sham tACS | 432 | – | – | – | – | |
Active tACS | 408 | 19 | − 27, 64 | 0.23 | − 0.30, 0.76 | |
Session | ||||||
1 | 280 | – | – | – | – | |
2 | 280 | − 44 | − 52, − 35 | − 0.33 | − 0.41, − 0.26 | < 0.001 |
3 | 280 | − 57 | − 65, − 49 | − 0.53 | − 0.60, − 0.45 | < 0.001 |
Trial type | < 0.001 | |||||
hpt | 420 | – | – | – | – | |
lpt | 420 | 7.3 | 3.8, 11 | 0.09 | 0.05, 0.13 | |
Epoch | 840 | − 13 | − 17, − 8.9 | − 0.17 | − 0.22, − 0.12 | < 0.001 |
Group * session | 840 | |||||
Active tACS * 2 | 136 | − 21 | − 30, − 12 | − 0.25 | − 0.36, − 0.15 | < 0.001 |
Active tACS * 3 | 136 | − 21 | − 29, − 12 | − 0.25 | − 0.35, − 0.14 | < 0.001 |